Cargando…

Drug Utilization Evaluation of Imipenem and Intravenous Ciprofloxacin in a Teaching Hospital

Drug Utilization Evaluation (DUE) studies are designed to assess drug usage appropriateness. We aim to evaluate the drug utilization of intravenous ciprofloxacin and imipenem, two of the broad spectrum antibiotics that consume a significant proportion of our hospitals’ outlay, in different wards of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mousavi, Sarah, Behi, Mehdi, Taghavi, Mohammad Reza, Ahmadvand, Alireza, Ziaie, Shadi, Moradi, Mandana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813373/ https://www.ncbi.nlm.nih.gov/pubmed/24250684

Ejemplares similares

Assessment of Biofilm Formation and Resistance to Imipenem and Ciprofloxacin among Clinical Isolates of Acinetobacter baumannii in Tehran
por: Abdi-Ali, Ahya, et al.
Publicado: (2014)

Effect of sub-MIC values of metronidazole, ciprofloxacin, and imipenem on the growth and toxin production in Clostridioides difficile
por: Shayegan Mehr, Farahnaz Sadat, et al.
Publicado: (2019)

Potential drug-drug interactions in prescriptions dispensed in community and hospital pharmacies in East of Iran
por: Dirin, Mandana Moradi, et al.
Publicado: (2014)

Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin
por: Chen, Chang-Hua, et al.
Publicado: (2017)

Adverse drug reactions induced by cardiovascular drugs in outpatients
por: Gholami, Kheirollah, et al.
Publicado: (2008)

Post-traumatic endophthalmitis prophylaxis with oral ciprofloxacin in comparison to intravenous cephazolin/gentamicin
por: Dehghani, Alireza, et al.
Publicado: (2018)

Detection of adeABC efllux pump encoding genes and antimicrobial effect of Mentha longifolia and Menthol on MICs of imipenem and ciprofloxacin in clinical isolates of Acinetobacter baumannii
por: Mahmoudi, Hassan, et al.
Publicado: (2020)

Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach
por: Ghazi, Islam M., et al.
Publicado: (2020)

A bibliometric study of publication patterns in rational use of medicines in Iran
por: Mousavi, Sarah, et al.
Publicado: (2013)

Correction: Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach
por: Ghazi, Islam M., et al.
Publicado: (2020)

Genomic Characterization of Imipenem- and Imipenem-Relebactam-Resistant Clinical Isolates of Pseudomonas aeruginosa
por: López-Pérez, Mario, et al.
Publicado: (2021)

Activity of imipenem/relebactam on Klebsiella pneumoniae with different mechanisms of imipenem non-susceptibility
por: Mashaly, Mervat El-Sayed, et al.
Publicado: (2021)

Utilization of Activated Carbon Catalyzed Ozonation (ACCO) For Removal of Ciprofloxacin and Vancomycin from Hospital Wastewater
por: Ghanbari Ghozikali, Mohammad, et al.
Publicado: (2023)

Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
por: Kiani, Masoumeh, et al.
Publicado: (2021)

Comparison of the effects of Lactobacillus plantarum versus imipenem on infected burn wound healing
por: Soleymanzadeh Moghadam, Somayeh, et al.
Publicado: (2020)

In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran
por: Malekzadegan, Yalda, et al.
Publicado: (2019)

Evaluation of a Novel Herbal Immunomodulator Drug (IMOD) in Treatment of Experimental Canine Visceral leishmaniasis
por: Malmasi, Abdolali, et al.
Publicado: (2014)

Optimal Aminoglycoside Therapy Following the Sepsis: How Much Is Too Much?
por: Mahmoudi, Laleh, et al.
Publicado: (2013)

Predicting Factors for the Pattern of Intravenous Immunoglobulin Utilization in a Middle Eastern University Hospital
por: Fakhari, Zeinab, et al.
Publicado: (2018)

1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections
por: Brown, Michelle, et al.
Publicado: (2018)

Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study
por: Brown, Michelle L, et al.
Publicado: (2020)

Organic anion transporters also mediate the drug–drug interaction between imipenem and cilastatin
por: Zhu, Yanna, et al.
Publicado: (2020)

The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa
por: Shahbandeh, Mahsa, et al.
Publicado: (2020)

Disposition kinetics and urinary excretion of ciprofloxacin in goats following single intravenous administration
por: Raina, R., et al.
Publicado: (2008)

Audit of IV pantoprazole: pattern of administration and compliance with guideline in a teaching hospital
por: Moradi, Mandana, et al.
Publicado: (2016)

Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review
por: Mousavi, Sarah, et al.
Publicado: (2015)

Assessment of the Effects of a Novel Herbal Immunomodulator Drug (IMOD) on Cytokine Profiles in Experimental Canine Visceral Leishmaniasis: a Preliminary Survey
por: MALMASI, Abdolali, et al.
Publicado: (2014)

Mutation of CarO participates in drug resistance in imipenem‐resistant Acinetobacter baumannii
por: Zhu, Li‐Jing, et al.
Publicado: (2019)

Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa
por: Farhan, Sara Mahmoud, et al.
Publicado: (2021)

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
por: Motsch, Johann, et al.
Publicado: (2020)

Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin †
por: Acebedo-Martínez, Francisco Javier, et al.
Publicado: (2023)

Determination of imipenem efflux-mediated resistance in Acinetobacter spp., using an efflux pump inhibitor
por: Amiri, Ghazale, et al.
Publicado: (2019)

Incidence of imipenem-resistant Acinetobacter baumannii in a general intensive care unit (ICU)
por: Alavi-Moghadam, Mostafa, et al.
Publicado: (2014)

Pharmacokinetics and Tolerability of Intravenous Sulbactam-Durlobactam with Imipenem-Cilastatin in Hospitalized Adults with Complicated Urinary Tract Infections, Including Acute Pyelonephritis
por: Sagan, Olexiy, et al.
Publicado: (2020)

Imipenem resistance in clinical Escherichia coli from Qom, Iran
por: Shams, Saeed, et al.
Publicado: (2018)

Zosteriform-Fixed Drug Eruption Secondary to Ciprofloxacin
por: Bhushan, Ravi, et al.
Publicado: (2021)

Dual-drug (Curcumin/Ciprofloxacin) loading and release from chitosan-based hydrogels embedded with magnetic Montmorillonite/Hyaluronic acid for enhancing wound healing
por: Sayyar, Zahra, et al.
Publicado: (2023)

Comparing the Characteristics of Mucormycosis Between Cases with and without COVID-19; a Cross-sectional Study
por: Sistanizad, Mohammad, et al.
Publicado: (2022)

Transcriptome profiling in imipenem-selected Acinetobacter baumannii
por: Chang, Kai-Chih, et al.
Publicado: (2014)

Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa
por: Xu, Ye, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nl2oj1tlv38b3lc8qnrtkvp3go